Two-year Safety Study of Dorzolamide as Monotherapy and with Timolol and Pilocarpine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two-year Safety Study of Dorzolamide as Monotherapy and with Timolol and Pilocarpine

Published:1998-12 Issue:6 Volume:7 Page:395???401
ISSN:1057-0829
Container-title:Journal of Glaucoma
language:en
Short-container-title:Journal of Glaucoma

Author:

Adamsons Ingrid A.,Polls Adam,Ostrov Charles S.,Boyle Janet E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Effectiveness of Using a Fixed Combination of Dorzolamide 2.0 % and Timolol 0.5 % in Primary Open-Angle Glaucoma;Ophthalmology in Russia;2024-06-28

2. Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy;Frontiers in Toxicology;2023-07-21

3. A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications;Ophthalmology and Therapy;2022-08-09

4. Ocular Surface Disease and Anti-Glaucoma Medications: Various features, Diagnosis, and Management Guidelines;Seminars in Ophthalmology;2022-08-01

5. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation;Expert Opinion on Drug Safety;2017-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP